MCID: MYC007
MIFTS: 77

Myocardial Infarction

Categories: Genetic diseases, Cardiovascular diseases

Aliases & Classifications for Myocardial Infarction

MalaCards integrated aliases for Myocardial Infarction:

Name: Myocardial Infarction 54 38 12 29 52 42 14 69
Myocardial Infarction 1 71 29
Heart Attack 12 41
Myocardial Infarction, Protection Against 54
Myocardial Infarction, Decreased 54
Premature Myocardial Infarction 71
Myocardial Infarct 12
Mci1 71

Classifications:



External Ids:

OMIM 54 608446
Disease Ontology 12 DOID:5844
ICD10 33 I21 I22
MeSH 42 D009203
NCIt 47 C27996
UMLS 69 C0027051

Summaries for Myocardial Infarction

MedlinePlus : 41 each year over a million people in the u.s. have a heart attack. about half of them die. many people have permanent heart damage or die because they don't get help immediately. it's important to know the symptoms of a heart attack and call 9-1-1 if someone is having them. those symptoms include chest discomfort - pressure, squeezing, or pain shortness of breath discomfort in the upper body - arms, shoulder, neck, back nausea, vomiting, dizziness, lightheadedness, sweating these symptoms can sometimes be different in women. what exactly is a heart attack? most heart attacks happen when a clot in the coronary artery blocks the supply of blood and oxygen to the heart. often this leads to an irregular heartbeat - called an arrhythmia - that causes a severe decrease in the pumping function of the heart. a blockage that is not treated within a few hours causes the affected heart muscle to die. nih: national heart, lung, and blood institute

MalaCards based summary : Myocardial Infarction, also known as myocardial infarction 1, is related to angina pectoris and pericarditis, and has symptoms including angina pectoris, chest pain and edema. An important gene associated with Myocardial Infarction is ACE (Angiotensin I Converting Enzyme), and among its related pathways/superpathways are Response to elevated platelet cytosolic Ca2+ and Transcriptional activation by NRF2. The drugs Abciximab and Everolimus have been mentioned in the context of this disorder. Affiliated tissues include Bone and Limb, and related phenotypes are cardiovascular system and homeostasis/metabolism

Disease Ontology : 12 A coronary artery disease characterized by myocardial cell death (myocardial necrosis) due to prolonged ischaemia.

UniProtKB/Swiss-Prot : 71 Myocardial infarction 1: A condition defined by the irreversible necrosis of heart muscle secondary to prolonged ischemia.

Wikipedia : 72 Myocardial infarction (MI), commonly known as a heart attack, occurs when blood flow decreases or stops... more...

Description from OMIM: 608446

Related Diseases for Myocardial Infarction

Diseases in the Myocardial Infarction family:

Myocardial Infarction 2 Acute Myocardial Infarction
Posterior Myocardial Infarction Myocardial Infarction, Susceptibility to, 1

Diseases related to Myocardial Infarction via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 444)
id Related Disease Score Top Affiliating Genes
1 angina pectoris 32.2 ACE APOB PLAT
2 pericarditis 32.2 ACE APOB OLR1 PLAT PTGIS
3 peripheral artery disease 31.7 ACE APOB MEF2A PLAT
4 acute myocardial infarction 12.4
5 inferior myocardial infarction 12.2
6 posterior myocardial infarction 12.2
7 lateral myocardial infarction 12.2
8 anterolateral myocardial infarction 12.2
9 silent myocardial infarction 12.1
10 myocardial infarction 2 12.1
11 anteroseptal myocardial infarction 12.1
12 subendocardial myocardial infarction 12.1
13 apical myocardial infarction 12.1
14 posterolateral myocardial infarction 12.1
15 acute anterolateral myocardial infarction 12.1
16 posteroinferior myocardial infarction 12.1
17 septal myocardial infarction 12.1
18 inferolateral myocardial infarct 12.1
19 acute inferolateral myocardial infarction 12.1
20 subendocardial infarction acute myocardial infarction 11.9
21 strictly posterior acute myocardial infarction 11.9
22 myocardial infarction, susceptibility to, 1 11.9
23 coronary artery disease, autosomal dominant, 1 11.6
24 coronary thrombosis 11.6
25 coronary artery disease 11.4
26 stroke, ischemic 11.3 ACE APOB F7 PLAT PTGIS
27 macular degeneration, age-related, 12 11.3 ACE APOB F7 MEF2A PLAT
28 kawasaki disease 11.3
29 malignant type ab thymoma 11.2 ACE APOB F7 PLAT
30 islet cell tumor 11.2 ACE APOB F7
31 autoimmune hepatitis 11.2 APOB OLR1 PLAT PTGIS
32 hypertension, essential 11.1 ACE APOB PLAT PTGIS
33 werner syndrome 11.1
34 xk aprosencephaly 11.1 APOB F13A1
35 conjunctival disease 11.0 ACE PLAT
36 ventricular fibrillation, familial, 1 11.0
37 coronary artery disease, autosomal dominant, 2 10.9
38 chronic mountain sickness 10.9
39 morbid obesity and spermatogenic failure 10.9
40 arterial calcification of infancy 10.9
41 hyperlipidemia, familial combined 10.9
42 hyperlipoproteinemia, type iii 10.9
43 thrombocythemia 3 10.9
44 thrombophilia due to thrombomodulin defect 10.9
45 aldosterone-producing adenoma 10.9
46 cataract, autosomal dominant congenital 4 10.8 ACE APOB
47 chronic diarrhea due to guanylate cyclase 2c overactivity 10.6 ACE PLAT
48 cardiogenic shock 10.6
49 thrombosis 10.6
50 artery disease 10.6

Graphical network of the top 20 diseases related to Myocardial Infarction:



Diseases related to Myocardial Infarction

Symptoms & Phenotypes for Myocardial Infarction

Clinical features from OMIM:

608446

UMLS symptoms related to Myocardial Infarction:


angina pectoris, chest pain, edema

MGI Mouse Phenotypes related to Myocardial Infarction:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.13 F7 GUCY1A3 ITGB3 LTA MEF2A OLR1
2 homeostasis/metabolism MP:0005376 10.1 ACE APOB ESR1 F13A1 F7 GCLC
3 mortality/aging MP:0010768 9.97 GCLC GCLM GUCY1A3 ITGB3 LRP8 LTA
4 muscle MP:0005369 9.5 APOB ESR1 GUCY1A3 ITGB3 MEF2A OLR1
5 respiratory system MP:0005388 9.17 ESR1 F13A1 GUCY1A3 ITGB3 LTA MEF2A

Drugs & Therapeutics for Myocardial Infarction

Drugs for Myocardial Infarction (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 925)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Abciximab Approved Phase 4,Phase 3,Phase 2 143653-53-6
2
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1 159351-69-6 6442177
3
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 22916-47-8 4189
4
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 53123-88-9 5284616 6436030 46835353
5
Etanercept Approved, Investigational Phase 4,Phase 1,Phase 2 185243-69-0
6
Pravastatin Approved Phase 4,Phase 3,Phase 2 81093-37-0 54687
7
Colchicine Approved Phase 4,Phase 3,Phase 2 64-86-8 6167 2833
8
Ticagrelor Approved Phase 4,Phase 3,Phase 2,Phase 1 274693-27-5 9871419
9
Ticlopidine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 55142-85-3 5472
10
Tirofiban Approved Phase 4,Phase 3,Phase 2,Phase 1 144494-65-5 60947
11
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-78-2 2244
12
Bivalirudin Approved, Investigational Phase 4,Phase 3,Phase 2 128270-60-0 16129704
13
Heparin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 9005-49-6 772 46507594
14
Tenecteplase Approved Phase 4,Phase 3,Phase 2 191588-94-0
15
Thrombin Approved Phase 4,Phase 3,Phase 2
16
Nicorandil Approved Phase 4,Phase 3 65141-46-0 47528
17
Eptifibatide Approved, Investigational Phase 4,Phase 3,Phase 2 188627-80-7 123610
18
Coal tar Approved Phase 4,Phase 2 8007-45-2
19
Chlorhexidine Approved, Vet_approved Phase 4 55-56-1 9552079 2713
20
Citalopram Approved Phase 4,Phase 2 59729-33-8 2771
21
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1 73590-58-6 4594
22
Pantoprazole Approved Phase 4,Phase 3 102625-70-7 4679
23
Clonidine Approved Phase 4,Phase 3,Early Phase 1 4205-90-7 2803
24
Phenprocoumon Approved Phase 4,Phase 3 435-97-2 9908 54680692
25
Warfarin Approved Phase 4,Phase 2,Phase 3 81-81-2 6691 54678486
26
Celecoxib Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 169590-42-5 2662
27
Menthol Approved Phase 4,Phase 2,Phase 3,Early Phase 1 2216-51-5 16666
28
Cilostazol Approved Phase 4,Phase 3 73963-72-1 2754
29
Chromium Approved Phase 4,Phase 2,Phase 3 7440-47-3 27668
30
Ramipril Approved Phase 4,Phase 3,Phase 2 87333-19-5 5362129
31
Telmisartan Approved, Investigational Phase 4,Phase 3,Phase 2 144701-48-4 65999
32
Acenocoumarol Approved Phase 4,Phase 3 152-72-7 9052 54676537
33
Salicylic acid Approved, Vet_approved Phase 4,Phase 3 69-72-7 338
34
Paclitaxel Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 33069-62-4 36314
35
Amiloride Approved Phase 4,Phase 3 2016-88-8, 2609-46-3 16231
36
Amlodipine Approved Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1 88150-42-9 2162
37
Simvastatin Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 79902-63-9 54454
38
Acarbose Approved, Investigational Phase 4,Phase 3,Phase 2 56180-94-0 441184
39
Methylprednisolone Approved, Vet_approved Phase 4,Phase 2 83-43-2 6741
40
Prednisolone Approved, Vet_approved Phase 4,Phase 2 50-24-8 5755
41
Rivaroxaban Approved Phase 4,Phase 2,Phase 3 366789-02-8
42
Ethanol Approved Phase 4,Phase 3,Early Phase 1 64-17-5 702
43
Desflurane Approved Phase 4 57041-67-5 42113
44
Isoflurane Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 26675-46-7 3763
45
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 2078-54-8 4943
46
Insulin Glargine Approved Phase 4,Phase 3 160337-95-1
47
Metformin Approved Phase 4,Phase 2,Phase 3,Early Phase 1 657-24-9 14219 4091
48
Zinc Approved Phase 4,Phase 3,Phase 1 7440-66-6 32051 23994
49
Udenafil Approved, Investigational Phase 4 268203-93-6 6918523
50
Valsartan Approved, Investigational Phase 4,Phase 3,Phase 2 137862-53-4 60846

Interventional clinical trials:

(show top 50) (show all 4246)

id Name Status NCT ID Phase Drugs
1 Sirolimus Eluting Stenting in Acute Myocardial Infarction Unknown status NCT00288210 Phase 4
2 Etanercept Treating Patient With Acute ST Segment Elevated Myocardial Infarction Unknown status NCT01372930 Phase 4 Etanercept;saline
3 Efficacy of Thrombosuction in Primary Percutaneous Coronary Intervention of Acute Myocardial Infarction Unknown status NCT01156662 Phase 4
4 Pravastatin for Acute Myocardial Infarction With Minimally to Mildly Increased Levels of Serum Cholesterol Study Unknown status NCT00688922 Phase 4 Pravastatin
5 Thrombus Aspiration During Percutaneous Coronary Intervention in Acute Non-ST-elevation Myocardial Infarction Study Unknown status NCT01013038 Phase 4
6 Colchicine in ST-elevation Myocardial Infarction Unknown status NCT01936285 Phase 4 Colchicine 2 mg loading dose; 0.5 mg bid for 5 days;Placebo
7 Reverse the HYpoTHyroid Status in Acute Myocardial InfarCtion (RHYTHMIC) Unknown status NCT02512978 Phase 4 Levothyroxine
8 Randomized Trial of Standard vs ClearWay-infused Abciximab and Thrombectomy for Myocardial Infarction Unknown status NCT01499407 Phase 4 Abciximab
9 Comparison of Ticagrelor And Clopidogrel on Inflammatory Biomarkers And Vascular Endothelial Function Unknown status NCT02123004 Phase 4 Ticagrelor;Clopidogrel
10 Multicentre 2x2 Factorial Randomised Study Comparing Tirofiban Versus Abciximab and SES Versus BMS in AMI Unknown status NCT00229515 Phase 4
11 Comparison of Primary PCI vs. Post-thrombolysis PCI as Reperfusion Strategies in STEMI Unknown status NCT02268669 Phase 4
12 Anti-Restenosis After AMI by Erythropoietin Unknown status NCT00423020 Phase 4 Erythropoietin
13 Efficacy Study of Combined Prasugrel and Bivalirudin Versus Clopidogrel and Heparin in Myocardial Infarction Unknown status NCT00976092 Phase 4 Prasugrel;Bivalirudin;Clopidogrel;Heparin
14 Intracoronary Bolus Only Compared With Intravenous Bolus and 12-hours Infusion of Abciximab in Non-ST Elevation Myocardial Infarction. Unknown status NCT01080638 Phase 4 glycoprotein IIb/IIIa inhibitor (abciximab)
15 Microvascular Reperfusion Utilizing Sonothrombolysis in Acute Myocardial Infarction (MRUSMI TRIAL) Unknown status NCT02170103 Phase 4 Microbubbles
16 IRIS : Use of Implantable Defibrillator in High-Risk Patients Early After Acute Myocardial Infarction Unknown status NCT00157768 Phase 4
17 Effects of Intensive Statin Treatment on Left Ventricular Function Unknown status NCT01936103 Phase 4 standard group;intensive group
18 Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial Infarction Unknown status NCT02435797 Phase 4 Nicorandil;normal saline
19 Optimizing Infarct Size by Transforming Emergent Stenting Into an Elective Procedure Study Unknown status NCT01462188 Phase 4
20 Intracoronary Cocktail Injection Combined With Thrombus Aspiration in STEMI Patients Treated With Primary Angioplasty Unknown status NCT02592694 Phase 4 cocktail
21 Effect of Conditioning on Myocardial Damage in STEMI Unknown status NCT02158468 Phase 4
22 A Prospective, Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial Infarction Unknown status NCT01942070 Phase 4
23 Multivessel Stenting Versus Staged Revascularization With Zotarolimus-eluting Stent for STEMI Unknown status NCT01781715 Phase 4
24 Comparison of Biolimus A9 and Everolimus Drug-Eluting Stents in Patients With ST Segment Elevation Myocardial Infarction Unknown status NCT00888758 Phase 4
25 Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMI Unknown status NCT01158846 Phase 4 prasugrel/bivalirudin;clopidogrel/abciximab
26 Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin Unknown status NCT00370045 Phase 4 Bivalirudin with and without eptifibatide
27 Coronary Angioplasty in Octogenarians With Emergent Coronary Syndromes Unknown status NCT02126202 Phase 4
28 Intensive Statin Therapy in PCI Patient With Acute Coronary Syndrome Unknown status NCT01372839 Phase 4 Atorvastatin;Statin
29 MGuard Stent in ST-elevation Myocardial Infarction Unknown status NCT01124942 Phase 4
30 Randomized Trial of Creatine-kinase Leak After Rosuvastatin At the Time of Percutaneous Coronary Intervention Unknown status NCT01968577 Phase 4 Rosuvastatin
31 Ticagrelor and Clopidogrel on Reperfusion in Patients With AMI Unknown status NCT02233790 Phase 4 Ticagrelor;Clopidogrel
32 A Trial to Evaluate Efficacy of Heart-protecting Musk Pill Unknown status NCT01897805 Phase 4 Heart-protecting Musk Pill;Placebo
33 Thrombus Aspiration for OcLuded Coronary Artery Enhanced With Distal Injection Of Abciximab Unknown status NCT01383785 Phase 4
34 N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure Unknown status NCT00692718 Phase 4 Epadel, Eicosapentaenoic acid
35 Local Thrombolytics Before Thrombectomy in STEMI Unknown status NCT01568931 Phase 4 Urokinase;Saline
36 the Effect of Danhong Injection on Microcirculation in the Treatment of Patients With STEMI After the PTCA Surgery. Unknown status NCT02158559 Phase 4 Danhong Injection;Normal Saline
37 Polish-Italian-Hungarian RAndomized ThrombEctomy Trial Unknown status NCT00377650 Phase 4
38 A Study to Evaluate Safety and Efficacy of the ExcelTM Sirolimus Eluting Stent With a Biodegradable Polymer Versus Sirolimus Eluting Stent With Non-Biodegradable Polymer in the Treatment of Patients With de Novo Coronary Artery Lesions Unknown status NCT00825773 Phase 4
39 Dissecting the Role of Distal Embolization of Athero-thrombotic Material in Primary PCI: the ThrombOticBurden and mIcrovAscularobStruction (TOBIAS) Study. Unknown status NCT01914055 Phase 4
40 Treating Acute MI Patients With Aggrastat on Their Way to Hospital Unknown status NCT00300833 Phase 4 Tirofiban
41 HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study) Unknown status NCT00106886 Phase 4 Folic acid, vitamin B6 and B12 or placebo
42 Post-MI PET Scan Imaging of Inflammation Unknown status NCT02281305 Phase 4 Colchicine
43 DECARD: Study of Escitalopram in the Prevention of Depression in Patients With Acute Coronary Syndrome Unknown status NCT00140257 Phase 4 Escitalopram
44 Comparing Ticagrelor and Clopidogrel Pharmacodynamics After Thrombolysis Unknown status NCT02048085 Phase 4 Ticagrelor;Clopidogrel
45 Zotarolimus and Everolimus-Eluting Stents ProsPectively Compared in Real World Unknown status NCT00768846 Phase 4
46 Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome Unknown status NCT02446730 Phase 4 Prasugel;Clopidogrel
47 Assessment of Coronary Flow Reserve by Doppler Flow WIre in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Differences Between the Loading Dose of Prasugrel and Ticagrelor . Unknown status NCT02032303 Phase 4 Ticagrelor loading;Prasugrel loading
48 Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing Unknown status NCT00698607 Phase 4 6-month clopidogrel therapy;12-month clopidogrel therapy
49 Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN) Unknown status NCT01735227 Phase 4 omeprazole;Pantoprazole
50 EPIC (Evaluating Perioperative Ischemia Reduction by Clonidine) Unknown status NCT00335582 Phase 4 clonidine hydrochloride

Search NIH Clinical Center for Myocardial Infarction

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Myocardial Infarction cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Myocardial Infarction:
ADRCs, adipose-derived regenerative cells for cardiovascular disease
AMI MultiStem
AMR-001, bone marrow-derived CD34+ cells for myocardial infarction
Autologous bone marrow-derived mononuclear cells for myocardial infarction
Bone marrow or peripheral blood-derived stem cells for treatment of myocardial ischemia
Bone marrow-derived adult mononuclear cells for heart diseases
Bone marrow-derived CD133+ vs. mononuclear cells for treatment of myocardial infarction
Bone marrow-derived mesenchymal stem cells for treatment of myocardial ischemia
Bone marrow-derived mononuclear cells for acute myocardial infarction
Bone marrow-derived mononuclear cells for chronic myocardial infarction
Bone marrow-derived mononuclear cells for myocardial infarction
Bone marrow-derived mononuclear cells for myocardial infarction
Bone marrow-derived mononuclear cells for myocardial infarction
Bone marrow-derived mononuclear cells for treatment of myocardial infarction
Bone marrow-derived progenitor cells for myocardial infarction
Bone marrow-derived stem cells for treatment of ischemic cardiomyopathy
Cardiosphere-derived autologous stem cells for reverse ventricular dysfunction
Cardiosphere-derived cells for the treatment of myocardial infarction
CD133+ bone marrow-derived stem cells in conjuction with coronary artery bypass grafting
Combination therapy of mononuclear cells with laser for coronary disease
Early endothelial progenitor cells for acute myocardial infarction
Embryonic stem cell-derived cardiomyocyte transplantation for myocardial infarction
Embryonic stem cell-derived cardiomyocytes for treatment of myocardial infarction
Enriched bone marrow-derived progenitor cells for heart diseases
Hearticellgram
Hydrogels with cardiomyocytes for myocardial repair
Induced pluripotent stem cells for treatment of myocardial infarction
itMSC, bone marrow-derived mesenchymal stem cells for cardiovascular diseases
Mesenchymal precursor cells for cardiovascular diseases
Mesendo, stem cell combination for treatment of cardiovascular diseases
MyoCell
Prochymal
Sca-1-positive cardiac progenitor cells for treatment of myocardial infarction
Stem cell therapy for treatment of acute myocardial infarction
StempeucelAMI
Umbilical cord blood-derived CD133 positive cells for treatment of myocardial infarction
Embryonic/Adult Cultured Cells Related to Myocardial Infarction:
Adipose-derived stem and regenerative cells PMIDs: 21082397 22281257
Bone marrow-derived adherent progenitor cells (MultiStem) PMIDs: 23111647 22004910 22052917 21175285
Bone marrow-derived autologous CD34+cells (AMR-001) PMIDs: 21167340
Bone marrow-derived mononuclear cells PMIDs: 19002124
Bone marrow-derived mononuclear cells
Peripheral blood-derived hematopoietic stem cells (family)
Bone marrow-derived mononuclear cells PMIDs: 22137069 19699857 20445812 20524773
Bone marrow-derived CD133+ hematopoietic stem cells
Bone marrow-derived mononuclear cells (family) PMIDs: 16889856 16382259 22192151 21414223 21392602 22940024
Bone marrow-derived mesenchymal stem cells (family)
Bone marrow-derived mononuclear cells
Bone marrow-derived mesenchymal stem cells PMIDs: 16889856 16382259
Bone marrow-derived mononuclear cells PMIDs: 22834565
Bone marrow-derived mononuclear cells PMIDs: 22834565
Bone marrow-derived mononuclear cells
Bone marrow-derived progenitor cells PMIDs: 20448133 16159812 18293890
Porcine bone marrow-derived mesenchymal stem cells PMIDs: 21392602 22940024 19958962
Bone marrow-derived mesenchymal stem cells PMIDs: 21392602 22940024
Cardiosphere-derived cells PMIDs: 22336189 17283259
Bone marrow-derived CD133+ cells PMIDs: 17320570
Peripheral blood-derived endothelial progenitor cells PMIDs: 21362705 22239631
eNOS-transfected endothelial progenitor cells PMIDs: 21362705 22239631
Cardiomyocyte-like cells PMIDs: 17980256 21783246
Cardiomyocyte-like cells PMIDs: 22040108
Bone marrow-derived progenitor cells PMIDs: 23362308 22936827 18794392 16990384 16990385 22651868
Neonatal rat ventricular cardiomyocytes PMIDs: 21783246
DR4 induced pluripotent stem cells PMIDs: 23568891
Mesenchymal Precursor Cells (STRO-3 selected) PMIDs: 20850099 21155976
Bone marrow-derived mesenchymal stem cells PMIDs: 21323410 20631864
Bone marrow-derived mononuclear cells PMIDs: 21323410 20631864
Skeletal myoblasts (MyoCell PMIDs: 19051139 15615560 16446778
Bone marrow-derived mesenchymal stem cells PMIDs: 19958962
Cardiac progenitor cells (Sca1+) PMIDs: 21980409
Bone marrow-derived CD34+/CXCR4+ cells
Bone marrow-derived mesenchymal stem cells (Stempeucel PMIDs: 18720444
Umbilical cord blood-derived CD133+ cells PMIDs: 16195418

Cochrane evidence based reviews: myocardial infarction

Genetic Tests for Myocardial Infarction

Genetic tests related to Myocardial Infarction:

id Genetic test Affiliating Genes
1 Myocardial Infarction 1 29
2 Myocardial Infarction 29

Anatomical Context for Myocardial Infarction

MalaCards organs/tissues related to Myocardial Infarction:

39
Heart, Bone, Endothelial, Kidney, Testes, Brain, Bone Marrow
LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database

Cells/anatomical compartments in embryo or adult related to Myocardial Infarction:
id Tissue Anatomical CompartmentCell Relevance
1 Bone Bone Marrow Bone Marrow Stromal Cells Potential therapeutic candidate
2 Limb Pelvic Girdle Bone Marrow Stromal Cells Potential therapeutic candidate
3 Heart Myocardium Cardiomyocytes Affected by disease

Publications for Myocardial Infarction

Articles related to Myocardial Infarction:

(show top 50) (show all 7168)
id Title Authors Year
1
The Endothelial Nitric Oxide Synthase Gene T-786C Polymorphism Increases Myocardial Infarction Risk: A Meta-Analysis. ( 28188309 )
2017
2
Clinical outcomes in myocardial infarction and multivessel disease after a cardiac rehabilitation programme: Partial versus complete revascularization. ( 28082243 )
2017
3
Fast assessment and management of chest pain patients without ST-elevation in the pre-hospital gateway (FamouS Triage): ruling out a myocardial infarction at home with the modified HEART score. ( 28084079 )
2017
4
Increased Hazard of Myocardial Infarction With Insulin-Provision Therapy in Actively Smoking Patients With Diabetes Mellitus and Stable Ischemic Heart Disease: The BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) Trial. ( 28903941 )
2017
5
Higher Risk of Bleeding in Asians Presenting With ST Elevation Myocardial Infarction (STEMI). ( 28946775 )
2017
6
TLR3 contributes to persistent autophagy and heart failure in mice after myocardial infarction. ( 28945004 )
2017
7
Acute transmural myocardial infarction by coronary embolism in a patient with JAK2 V617F-positive essential thrombocythemia. ( 28692109 )
2017
8
Long-term outcome and risk prediction in patients suffering acute myocardial infarction complicated by post-infarction cardiac rupture. ( 27847155 )
2017
9
What's in a Name? The New ICD-10 (10th Revision of the International Statistical Classification of Diseases and Related Health Problems) Codes and Type 2 Myocardial Infarction. ( 28947477 )
2017
10
Morphologically normalized left ventricular motion indicators from MRI feature tracking characterize myocardial infarction. ( 28947754 )
2017
11
Coronary Aneurysm Formation After Bioresorbable Vascular Scaffold Implantation Resulting in Acute Myocardial Infarction. ( 28512285 )
2017
12
Fibromuscular Dysplasia with Spontaneous Coronary Artery Disease Presenting as Acute Myocardial Infarction. ( 28652952 )
2017
13
Unexpected mirror-image dextrocardia in a patient with ST elevation myocardial infarction. ( 28891179 )
2017
14
Response by Heydari et al to Letter Regarding Article, "Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial". ( 28069718 )
2017
15
Right bundle branch block and anterior wall ST elevation myocardial infarction. ( 28840315 )
2017
16
Cardiac remodeling following reperfused acute myocardial infarction is linked to the concomitant evolution of vascular function as assessed by cardiovascular magnetic resonance. ( 28063459 )
2017
17
Trimethylamine N-oxide and Risk Stratification after Acute Myocardial Infarction. ( 28062632 )
2017
18
Changes in Sympathetic Innervation of the Heart in Rats with Experimental Myocardial Infarction. Effect of Semax. ( 28948544 )
2017
19
Non-ST-Elevation Myocardial Infarction (NSTEMI) outcome in type 2 diabetic patients with non-obstructive coronary artery stenosis: effects of incretin treatment. ( 28950045 )
2017
20
Factors associated with compliance to AHA/ACC performance measures in a myocardial infarction system of care in Brazil. ( 28531328 )
2017
21
Myocardial overexpression of TIMP3 after myocardial infarction exerts beneficial effects by promoting angiogenesis and suppressing early proteolysis. ( 28550172 )
2017
22
Antiplatelet Therapy and Clinical Outcomes Following Myocardial Infarction Among Patients in a U.S. Employer-Based Insurance Database. ( 28530518 )
2017
23
Tert-butylhydroquinone promotes angiogenesis and improves heart functions in rats after myocardial infarction. ( 28534651 )
2017
24
Pericardial mesothelioma presenting as a suspected ST-elevation myocardial infarction. ( 28343785 )
2017
25
Acute myocardial infarction in patients of nephrotic syndrome: a case series. ( 28868077 )
2017
26
Correlation between electrocardiographic changes and coronary findings in patients with acute myocardial infarction and single-vessel disease. ( 28936441 )
2017
27
Haplodeficiency of activin receptor-like kinase 4 alleviates myocardial infarction-induced cardiac fibrosis and preserves cardiac function. ( 28214509 )
2017
28
Prognostic Implications of Mid-Range Left Ventricular Ejection Fraction on Patients Presenting With ST-Segment Elevation Myocardial Infarction. ( 28532775 )
2017
29
Effect of Post-procedural Full Does Infusion of Bivalirudin on Acute Stent Thrombosis in Patients with ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Outcomes in a large real-world population. ( 28083915 )
2017
30
Mesenchymal Stem Cells with eNOS Over-Expression Enhance Cardiac Repair in Rats with Myocardial Infarction. ( 27913896 )
2017
31
Effects of neuregulin GGF2 (cimaglermin alfa) dose and treatment frequency on left ventricular function in rats following myocardial infarction. ( 27993643 )
2017
32
Influences of IL-1b-3953 C>T and MMP-9-1562Ca88>T Gene Variants on Myocardial Infarction Susceptibility in a Subset of the Iranian Population. ( 27824519 )
2017
33
The mitochondria-targeting peptide elamipretide diminishes circulating HtrA2 in ST-segment elevation myocardial infarction. ( 28534645 )
2017
34
Association between coronary atherosclerosis progression and in-stent neoatherosclerosis in patients with ST-elevation myocardial infarction at 5-years follow-up. ( 28943494 )
2017
35
Beta-blockers reduced the risk of cardiac rupture in patients with acute myocardial infarction: A meta-analysis of randomized control trials. ( 28109576 )
2017
36
Post-Myocardial Infarction Ventricular Septal Defect Six Months following Coronary Artery Bypass Grafting. ( 28846531 )
2017
37
Prognostic impact of unrecognized myocardial scar in the non-culprit territories by cardiac magnetic resonance imaging in patients with acute myocardial infarction. ( 28950314 )
2017
38
Circulating MicroRNA-145 is Associated with Acute Myocardial Infarction and Heart Failure. ( 28051023 )
2017
39
Expression pattern of genome-scale long noncoding RNA following acute myocardial infarction in Chinese Uyghur patients. ( 28418905 )
2017
40
Plasma apelin-12 levels may predict in-hospital major adverse cardiac events in ST-elevation myocardial infarction and the relationship between apelin-12 and the neutrophil/lymphocyte ratio in patients undergoing primary coronary intervention. ( 27770057 )
2017
41
Cardiac Troponin T: Smaller Molecules in Patients with End-Stage Renal Disease than after Onset of Acute Myocardial Infarction. ( 28073901 )
2017
42
Incidence of atrial fibrillation detected by continuous rhythm monitoring after acute myocardial infarction in patients with preserved left ventricular ejection fraction: results of the ARREST study. ( 28069838 )
2017
43
Relationship of long-term prognosis to MMP and TIMP polymorphisms in patients after ST elevation myocardial infarction. ( 28101856 )
2017
44
ECG stress test induced atrial ischemia in a patient with old inferior myocardial infarction due to a distal coronary artery lesion. ( 28270845 )
2017
45
Integrating invasive hemodynamic parameters into risk stratification of acute myocardial infarction and cardiogenic shock. ( 28891162 )
2017
46
Letter by Koh Regarding Article, "Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial". ( 28069716 )
2017
47
Gelatinases A and B and Antioxidant Enzyme Activity in the Early Phase of Acute Myocardial Infarction. ( 28374671 )
2017
48
[Retracted] Cathepsin B inhibition attenuates cardiac dysfunction and remodeling following myocardial infarction by inhibiting the NLRP3 pathway. ( 28944892 )
2017
49
History of erectile dysfunction as a predictor of poor physical performance after an acute myocardial infarction. ( 28067536 )
2017
50
MicroRNA-210-mediated proliferation, survival, and angiogenesis promote cardiac repair post myocardial infarction in rodents. ( 28948298 )
2017